![]() |
|
|
Vol. 54, Issue 4, 663-670, October 1998
Medical Research Council Toxicology Unit, Centre for Mechanisms of
Human Toxicity, University of Leicester, Leicester LE1 9HN, United
Kingdom
Protein kinase C (PKC) is an important constituent of the signaling
pathways involved in apoptosis. The PKC inhibitor staurosporine induces
apoptosis in many cell types. We characterized the role of PKC in the
induction of apoptosis in immature rat thymocytes by investigating the
effects of staurosporine with those of five analogs. Four of them, the
indolocarbazoles CGP 41251 and UCN-01 and the bisindolylmaleimides RO
31-8220 and GF 109203X, possess high PKC-inhibitory specificity and
potency, whereas one, the UCN-01 stereoisomer UCN-02, is a weak PKC
inhibitor. Apoptosis was examined by flow cytometry, internucleosomal
DNA cleavage, and formation of large DNA fragments. Staurosporine,
UCN-01, and UCN-02 induced a concentration- and time-dependent increase
in apoptosis, whereas neither CGP 41251, RO 31-8220, nor GF 109203X induced apoptosis. The mechanism of induction of apoptosis by staurosporine, UCN-01, and UCN-02 was clearly different from the mechanism that mediates induction of apoptosis by etoposide and dexamethasone, as judged by differential effects of modulators of
apoptosis. Staurosporine, UCN-01, and UCN-02 at concentrations of a
hundredth to a thousandth of those at which they induced apoptosis, and
RO 31-8220 inhibited apoptosis elicited by thapsigargin but not
apoptosis caused by dexamethasone or etoposide. The results suggest
that (i) UCN-01 and UCN-02 mimic staurosporine as inducers of thymocyte
apoptosis; (ii) staurosporine, UCN-01 and UCN-02 share a biphasic
effect on apoptosis in rat thymocytes, being inhibitory at low
concentrations and stimulatory at high concentrations; and (iii)
inhibition of PKC alone is insufficient for induction of apoptosis in
thymocytes.
This article has been cited by other articles:
![]() |
X.-K. Tong and E. Hamel Transforming Growth Factor-beta1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase Mol. Pharmacol., December 1, 2007; 72(6): 1476 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Duan, P. Hajek, C. Lin, S. K. Shin, G. Attardi, and A. Chomyn Mitochondrial Outer Membrane Permeability Change and Hypersensitivity to Digitonin Early in Staurosporine-induced Apoptosis J. Biol. Chem., January 3, 2003; 278(2): 1346 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dai, C. Yu, V. Singh, L. Tang, Z. Wang, R. McInistry, P. Dent, and S. Grant Pharmacological Inhibitors of the Mitogen-activated Protein Kinase (MAPK) Kinase/MAPK Cascade Interact Synergistically with UCN-01 to Induce Mitochondrial Dysfunction and Apoptosis in Human Leukemia Cells Cancer Res., July 1, 2001; 61(13): 5106 - 5115. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ponzanelli, M. Gianni, R. Giavazzi, A. Garofalo, I. Nicoletti, U. Reichert, E. Erba, A. Rambaldi, M. Terao, and E. Garattini Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid Blood, April 15, 2000; 95(8): 2672 - 2682. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Ward, E. H. Rogers, and E. S. Hunter III Comparative Pathogenesis of Haloacetic Acid and Protein Kinase Inhibitor Embryotoxicity in Mouse Whole Embryo Culture Toxicol. Sci., January 1, 2000; 53(1): 118 - 121. [Abstract] [Full Text] [PDF] |
||||